Comparison of Coronary CT Angiography to Invasive Coronary Angiography

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00146887
Recruitment Status : Unknown
Verified August 2005 by Hadassah Medical Organization.
Recruitment status was:  Recruiting
First Posted : September 7, 2005
Last Update Posted : November 7, 2006
Information provided by:
Hadassah Medical Organization

Brief Summary:
The purpose of the trial is to investigate the accuracy of coronary CT compared to the conventional "gold standard" cardiac catheterization.

Condition or disease Intervention/treatment Phase
Atherosclerosis, Coronary Procedure: coronary catheterization Not Applicable

  Show Detailed Description

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 40 participants
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Official Title: A Trial Comparing the Sensitivity and Specificity of Coronary Angiography With Coronary CT Angiography
Study Start Date : January 2005
Estimated Study Completion Date : August 2005

Primary Outcome Measures :
  1. CT sensitivity and specificity

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

40 Patients who are scheduled to undergo coronary angiogram will be recruited at Mount Scopus and Ein Kerem

Exclusion Criteria:

  1. CABG or stent implantation in the past.
  2. Atrial fibrillation
  3. Contraindication for beta blockers

    1. Obstructive pulmonary disease
    2. Severe peripheral vascular disease
    3. Sick sinus syndrome or AV block greater than 1st degree.
    4. Systolic blood pressure below 100 mm Hg.
  4. Renal disease or other conditions that might increase the risk of contrast nephropathy (diabetes mellitus, SLE, paraproteinemia, malignancy, liver disease)
  5. Allergy to contrast material.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00146887

Contact: Ronen Durst, MD 972-2-6777111

Hadassah Medical Center Recruiting
Jerusalem, Israel
Contact: Ronen Durst, MD    972-2-50-7874548   
Sponsors and Collaborators
Hadassah Medical Organization
Principal Investigator: ronen durst, MD Hadassah Medical Organization Identifier: NCT00146887     History of Changes
Other Study ID Numbers: 21-03.09.04-HMO-CTIL
Non applicable
First Posted: September 7, 2005    Key Record Dates
Last Update Posted: November 7, 2006
Last Verified: August 2005

Keywords provided by Hadassah Medical Organization:
Coronary CT

Additional relevant MeSH terms:
Coronary Artery Disease
Myocardial Ischemia
Arterial Occlusive Diseases
Vascular Diseases
Cardiovascular Diseases
Coronary Disease
Heart Diseases